Prostate Cancer | Specialty

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

Dr. Crawford Talks About Robotic Treatment

April 15th 2011

Immunotherapies: Avoiding collisions once the brake is released

April 13th 2011

Immunotherapies again made headlines in oncology last month

Dr. Crawford on Challenges Facing Active Surveillance

April 12th 2011

PSA: To Screen or Not to Screen

April 12th 2011

Screening for prostate cancer does work, despite controversy about its efficacy, according to IPCC Co-chair Leonard G. Gomella

Integrating New Hormonal Therapies in Advanced Disease

April 11th 2011

Hormonal therapies have long been the standard of care for metastatic advanced prostate cancer

Novel vaccine approaches: Prospects for PROSTVACÂ®-VF are bright

April 11th 2011

As research into novel vaccine approaches for treating advanced prostate cancer continues...

The Overtreatment of Prostate Cancer

April 11th 2011

Increased prostate cancer screening has led to overtreatment and has not significantly reduced mortality rates in prostate cancer

Dr. Dreicer on New Target Agents Improving Treatment

April 11th 2011

March Net Guide: Prostate Cancer

April 11th 2011

A guide to internet resources, CMEs, Clinical Trials and much more

New Diagnostic Tool May Improve Accuracy of PSA Screening

April 8th 2011

A new prostate cancer screening test yielded more detailed and specific results for prostate-specific antigen

Dr. Crawford on the Drawbacks of PSA Screening

April 8th 2011

Dr. Crawford Discusses the Benefits of PCA3 Testing

April 8th 2011

Bicalutamide Therapy Plus Radiation Improves PFS

April 8th 2011

Bicalutamide during and after radiation therapy reduced the risk of progression and the risk of metastatic disease in men with a rising prostate-specific antigen

Dr. Sandler on the Importance of Radiation Therapy

April 7th 2011

Dr. Crawford on Moving Prostate Cancer Field Forward

April 7th 2011

Dr. Gomella Discusses Interdisiplinary Treatment

April 6th 2011

Prostate Cancer Advances From the Past 10 Years

April 6th 2011

Recent Developments in Prostate Cancer

April 5th 2011

Hormonal and Radiation Therapy in Prostate Cancer

April 5th 2011

TAK-700 in Localized Prostate Cancer Clinical Trials

April 4th 2011

Dr. Howard Sandler from Cedars-Sinai Medical Center discusses the TAK-700 in Localized Prostate Cancer Clinical Trials